glp 1 optic nerve Anterior ischemic neuropathy in patients treated with semaglutide: report of four cases with a possible association | BMC Ophthalmology GLP-1 Users May Face Optic
Description
Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.
Coverage restrictions and high out-of-pocket costs
#glp1 #diabetes #medication #T2DM | 28 comments on LinkedIn
OBJECTIVES: Pediatric Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD), formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD) is characterized by hepatic steatosis with at least one risk factor indicative of cardiometabolic dysfunction
If youve lost weight on semaglutide, tirzepatide, or another GLP-1 medication, youve []
